[Skip to Content]
[Skip to Content Landing]
October 1995

Five-Year Follow-up After Radical Surgery for Colorectal CancerResults of a Prospective Randomized Trial

Author Affiliations

From the Department of Surgery, Oulu University Hospital, Oulu, Finland.

Arch Surg. 1995;130(10):1062-1067. doi:10.1001/archsurg.1995.01430100040009

Objective:  To determine whether an intensified follow-up of patients with colorectal cancer can lead to improved reresectability and a better long-term survival.

Design:  A prospective randomized trial of 106 patients.

Setting:  Oulu University Hospital, a referral center in northern Finland.

Patients:  A total of 106 consecutive patients who underwent radical resection for colorectal cancer, 54 of whom were randomized into a conventional follow-up group and 52 into an intensified follow-up group.

Main Outcome Measures:  After a 5-year follow-up, the time of detection of recurrence, the recurrence rates, the first method showing recurrence, the mode of recurrence, reresectability, and survival were compared between the groups.

Results:  The recurrences were identified earlier in the intensified follow-up group than in the conventional follow-up group (mean±SD, 10±5 months vs 15±10 months). The overall recurrence rate was 41%, with 39% in the conventional group and 42% in the intensified group. Carcinoembryonic antigen determination was the most common method showing recurrence in both groups. Endoscopy and ultrasound were beneficial in the intensified follow-up group, but computed tomography failed to improve the diagnostics. The mode of recurrence did not differ between the groups. Radical reresections were performed on 19% (8/43) of the patients, 14% (3/21) in the conventional group and 22% (5/22) in the intensified group. The cumulative 5-year survival was 54% in the conventional group and 59% in the intensified group.

Conclusion:  Earlier detection of recurrent colorectal cancer by intensified follow-up does not lead to either significantly increased reresectability or improved 5-year survival.(Arch Surg. 1995;130:1062-1067)